Beijing Sannuo Jiayi Biotechnology Co., Ltd., established on 2002-05-29, Business scope includes medical technology development,Technology Promotion,technology transfer,technical consulting,Technical Services,Technical Training.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Research Development Foundation is an American private company that operates as noncommercial research organizations.

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.

Part of University of Adelaide, Adelaide Research & Innovation Pty Ltd. is an Australian company located in Adelaide. The firm provides analytical research services. Robert Chalmers is the current CEO of the firm.

MBL International Corp. supplies scientific and diagnostic research products. It offers antibodies, kits and assays, proteins, tetramers and monomers, cell culture, and miscellaneous. Its products are used in academic research institutions, pharmaceutical and biotechnology companies, government agencies as well as hospital and reference laboratories. The company was founded in 1993 and is headquartered in Woburn, MA.

New Geyuan (Nanjing) Biotechnology Co., Ltd., established on 2018-01-23, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:software development;Instrument Manufacturing;Engineering and Technology Research and Experimental Development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Instrument sales;Experimental analysis instrument sales;Manufacturing of experimental analysis instruments;Specialty Chemicals Sales(Free of Hazardous Chemicals);Production of Class I Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

Fluidigm Corporation is a biotechnology research agency that helps in improving health.

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

CytoGenix, Inc. is a biopharmaceutical company that develops and markets innovative compounds and services based on its proprietary gene regulating and DNA production technologies. CytoGenix has products in pre-clinical development including an antimicrobial compound, DNA vaccines and anti-herpes and anti-inflammatory topical creams. The Company has developed a cell free process for synthesizing DNA which it uses for its own products as well as marketing specific compounds to other companies. CytoGenix, Inc. currently has 11 granted patents (1 US, 1 China, 9 Europe) covering our basic ssDNA expression technology, with one additional allowance (India) pending. We have an additional 11 applications pending in various countries which are currently progressing through the normal prosecution process. The Company actively collaborates with numerous academic centers of excellence, government agencies and biotechnology industry partners. Cytogenix, Inc. is publicly traded under the symbol CYGX on the NASDAQ Over the Counter Bulletin Board.

DuPont offers sustainable solutions for agriculture, electronics, communications, construction, transportation, and apparel markets. Their products and services include construction materials, fabrics, packaging materials, medical devices, electronic solutions, and adhesives for markets. They provide specialized construction materials to create and maintain roads, bridges, telecommunications, power, and water plants.

NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Coley Pharmaceutical GmbH, part of Pfizer Inc., is a German company located in Berlin that provides research and development in the field of natural sciences, engineering, agricultural sciences and medicine. It was founded by Heather L. Davis.

Suzhou Huizhen Biotechnology Co., Ltd., established on 2017-09-04, Business scope includes technology development in the field of biomedical technology,technology transfer,technical consulting,Technical Services;Biological reagents and consumables,medical instruments,Research and Development of Electronic Instruments,Production,Sales;software development,Sales and related technical services;Engaged in the import and export business of the above commodities and technologies;Own house rental.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Engineering and Technology Research and Experimental Development;Domestic trade agent;Technology promotion and application services;Technical extension services;Information Technology Consulting Services;R&D of industrial enzyme preparations;Medical Research and Experimental Development;R&D and application of cell technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).